Frontiers in Oncology (Jan 2023)

A worldwide bibliometric analysis of malignant peripheral nerve sheath tumors from 2000 to 2022

  • Xingfeng Huang,
  • Zexin Fu,
  • Qinhao Gu,
  • Ji Wang,
  • Yi Sun,
  • Yong He,
  • Yong He,
  • Yong He,
  • Yong He,
  • Sufan Wu,
  • Xiaojie Hu,
  • Chengrui Guo

DOI
https://doi.org/10.3389/fonc.2023.1111985
Journal volume & issue
Vol. 13

Abstract

Read online

BackgroundCurrently, malignant peripheral nerve sheath tumors (MPNST) are the subject of intense research interest. However, bibliometric studies have not been conducted in this field. The purpose of the study was to identify historical trends and presents a bibliometric analysis of the MPNST literature from 2000 to 2022.MethodsFor the bibliometric analysis, publications were retrieved from the Web of Science database based on the following search terms: [TI = (MPNST) OR TI= (malignant peripheral nerve sheath tumors) AND PY = (2000–2022)]. The following information was collected for each document: the publication trends and geographical distribution, important authors and collaboration, keyword distribution and evaluation, most popular journals, and most influential articles.ResultsWe included 1400 documents for bibliometric analysis, covering five categories: 824 articles, 17 proceedings papers, 68 letters, 402 meeting abstracts, and 89 reviews. Corrections, editorials, book chapters, data papers, publications with expressed concerns, and retractions were excluded from our research.ConclusionSince 2000, the number of publications on MPNST has continuously increased. Among all countries that contributed to the MPNST research, the USA, Japan, and China were the three most productive countries. The journal Modern Pathology has the most publications on MPNST, while those in the Cancer Research journal were the most frequently cited. The University of Texas MD Anderson Cancer Center may be a good partner to collaborate with. Recent research trends in MPNST have focused on tumorigenesis, clinical management, and predictive biomarkers.

Keywords